Bladder cancer trials in United States

In United States 259 Also abroad 626

259 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
Where
Austin, Bakersfield, Bala-Cynwyd, Chicago Ridge, Cincinnati, Columbia, Germantown, Hialeah, Lafayette, Lincoln, Littleton, Los Alamitos, Los Angeles, New York, Portland, Seattle, Torrance, Virginia Beach
Age
18 years and over
People
308 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT06833073 · EU 2024-517335-46-00
Phase 1Taking people
Imaging Study of [89Zr]DFO-YS5 for Cancer Detection
Where
San Francisco
Age
18 years and over
People
40
Run by
Robert Flavell, MD, PhD
See details and how to joinNCT07664397
Phase 1Taking people
A Randomized Trial of Bicalutamide in Non-Muscle Invasive Bladder Cancer
Where
Bethesda, Columbus, Los Angeles, Madison, Rochester, Tucson
Age
18 years and over
People
80
Run by
University of Wisconsin, Madison
See details and how to joinNCT05521698
No phaseTaking people
Patient-Centered Surgical Prehabilitation
Where
Boston
Age
18 years to 85 years
People
25
Run by
Brigham and Women's Hospital
See details and how to joinNCT05715684
Phase 1/2Taking people
Enfortumab Vedotin and Stereotactic Radiation for Localized Bladder Cancer
Where
Dallas
Age
18 years and over
People
19
Run by
University of Texas Southwestern Medical Center
See details and how to joinNCT06394570
Phase 2Taking people
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Where
Jacksonville
Age
18 years and over
People
27
Run by
Mayo Clinic
See details and how to joinNCT07285044
No phaseTaking people
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
Where
Ann Arbor, Baltimore, Boston, Chapel Hill, Chicago, Columbia, Columbus, Dallas, Gainesville, Houston, Indianapolis, Iowa City, Lake Success, Miami, Nashville, New Brunswick, New York, Santa Monica, Syracuse, Tampa
Age
18 years and over
People
450
Run by
UroGen Pharma Ltd.
See details and how to joinNCT05874921
Phase 1Taking people
DK222 Study at Hopkins
Where
Baltimore
Age
18 years and over
People
6
Run by
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
See details and how to joinNCT07140315
Phase 1Taking people
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Where
Coral Springs, Duarte, East Brunswick, Fairfax, Fort Worth, Goodyear, Houston, Irving, Jacksonville, Nashville, New York, Omaha, Orlando, Philadelphia, Phoenix, Rochester, Santa Rosa, Seattle, Tampa, Washington D.C., West Valley City, Zion
Age
18 years and over
People
260
Run by
IDEAYA Biosciences
See details and how to joinNCT07277413
No phaseTaking people
DESTINY-PANTUMOUR04
Where
Birmingham, Boulder, Bullhead City, Canton, Casa Grande, Coral Springs, Dallas, Decatur, Durham, Farmington, Maumee, Nashville, Philadelphia, San Diego, St. Petersburg, Topeka, West Palm Beach, Wilson
Age
18 years to 130 years
People
100
Run by
AstraZeneca
See details and how to joinNCT07124000
Phase 1/2Taking people
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Where
Beverly Hills, Boston, Boynton Beach, Dallas, Glendale, Los Angeles, Nashville, Tacoma
Age
18 years and over
People
134
Run by
Neonc Technologies, Inc.
See details and how to joinNCT06047379
No phaseTaking people
Pan-tumor MRD Study
Where
Atlanta, Binghamton, Birmingham, Bullhead City, Canton, Casa Grande, Charlotte, Coral Springs, Corbin, Covington, Elizabethtown, Englewood, Farmington, Glendale, Goldsboro, Grand Rapids, Houston, Kingwood, Lancaster, Lexington, Lincoln, Little Rock, Louisville, Maumee, O'Fallon, Orange City, Oxnard, Portland, Richmond, Rochester, San Diego, Sayre, Shirley, Shreveport, Springdale, Springfield, Stockton, St. Petersburg, Tacoma, Texarkana, Topeka, Tulsa, Urbana, Wichita, Wilson, York
Age
18 years and over
People
1,350
Run by
Paradigm Health
See details and how to joinNCT06605404
Phase 1Not yet taking people in United States
N-803 in Combination With Pembrolizumab and Enfortumab Vedotin for Treatment of Urothelial Cancer
Where
San Francisco
Age
18 years and over
People
18
Run by
ImmunityBio, Inc.
See details and how to joinNCT07217496
Phase 3Taking people
A Study of Surgical Techniques During Cystectomy
Where
Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Rockville Centre
Age
21 years and over
People
530
Run by
Memorial Sloan Kettering Cancer Center
See details and how to joinNCT06703476
Phase 1Taking people
Pembrolizumab Plus CA-4948 for the Treatment of Patients With Progressive Metastatic Urothelial Cancer Despite Prior Immunotherapy
Where
Atlanta, Dallas, Duarte, Irvine, La Jolla, Miami, New York, Orange
Age
18 years and over
People
27
Run by
National Cancer Institute (NCI)
See details and how to joinNCT06439836
Phase 1Taking people
Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease
Where
Columbus, Orlando, St Louis
Age
18 years and over
People
64
Run by
Washington University School of Medicine
See details and how to joinNCT06529822
No phaseTaking people
Prehabilitation in High-risk Oncologic Surgery
Where
Philadelphia
Age
18 years and over
People
180
Run by
Fox Chase Cancer Center
See details and how to joinNCT07638410
Phase 1/2Taking people
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
Where
Austin, Grand Rapids, Houston, Huntersville, Miami, Minneapolis, Nashville, Salt Lake City, San Antonio, St Louis
Age
18 years and over
People
159 worldwide
Run by
Aulos Bioscience, Inc.
See details and how to joinNCT05267626
Phase 2Taking people
Photodynamic Diagnosis of Upper Tract Urothelial Carcinoma Using Fluorescence Endoscopy and Oral 5-ALA
Where
Detroit
Age
18 years to 75 years
People
10
Run by
Henry Ford Health System
See details and how to joinNCT06948552
Phase 2Taking people
A Cruciferous Vegetable Eating Program for the Reduction of Cancer Recurrence and Progression in Patients With Non-muscle Invasive Bladder Cancer
Where
Buffalo
Age
18 years and over
People
344
Run by
Roswell Park Cancer Institute
See details and how to joinNCT06733363
Phase 1Taking people
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
Where
Duarte, Glen Burnie, Grand Rapids, Houston, Iowa City, Irvine, Miami, New York, Orlando, Pittsburgh, Salt Lake City, Tampa, Westwood
Age
18 years and over
People
150
Run by
Aktis Oncology, Inc.
See details and how to joinNCT07020117
Phase 2Taking people
Gemcitabine and Carboplatin After Progression on Enfortumab Vedotin and Pembrolizumab in Advanced/Metastatic Urothelial Carcinoma
Where
Philadelphia
Age
18 years and over
People
55
Run by
Fox Chase Cancer Center
See details and how to joinNCT07043972
Phase 2Taking people
Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance
Where
Bay Pines, Charleston, Cleveland, Dallas, Lebanon, St Louis, Tampa, West Haven, West Roxbury, White River Junction
Age
18 years and over
People
240
Run by
White River Junction Veterans Affairs Medical Center
See details and how to joinNCT05796375
Phase 1Taking people
A Study of BMS-986504 With Standard-of-Care Therapy for People With Solid Tumor Cancer
Where
Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Uniondale
Age
18 years and over
People
60
Run by
Memorial Sloan Kettering Cancer Center
See details and how to joinNCT07532902
Phase 2Not yet taking people in United States
A Phase 2 Study Evaluating Bladder Preservation With Enfortumab Vedotin Plus Pembrolizumab in Patients With Muscle-Invasive Urothelial Cancer
Where
Salt Lake City
Age
18 years and over
People
25
Run by
University of Utah
See details and how to joinNCT07822373